Mimedx (MDXG) Total Liabilities (2010 - 2026)

Mimedx has disclosed Total Liabilities across 17 years of filings, most recently posting $65.0 million for Q2 2026.

• In Q2 2026, Total Liabilities fell 12.74% year-over-year to $65.0 million; the TTM figure through Jun 2026 stood at $65.0 million (down 12.74% YoY), while the FY2025 annual figure was $86.1 million, up 21.6% from the prior year.
• Total Liabilities came in at $65.0 million for Q2 2026 at Mimedx, down from $65.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $99.8 million in Q3 2022 to a low of $62.1 million in Q2 2024.
• Average Total Liabilities over 5 years is $81.0 million, with a median of $83.1 million recorded in 2025.
• Year-over-year, Total Liabilities sank 35.64% in 2024 and gained 27.29% in 2025.
• Over 5 years, Total Liabilities stood at $96.9 million in 2022, then decreased by 0.61% to $96.3 million in 2023, then retreated by 26.49% to $70.8 million in 2024, then grew by 21.6% to $86.1 million in 2025, then declined by 24.52% to $65.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $65.0 million in Q2 2026, $65.7 million in Q1 2026, and $86.1 million in Q4 2025.